Due to the production and supply chain issues with these drugs, people were allowed to use non-FDA-approved clones, says Nebraska Medicine bariatric surgeon Cori McBride, MD
Liraglutide (LEADER trial), semaglutide (SUSTAIN-6), and dulaglutide (REWIND trial) demonstrated significant reductions in major adverse cardiovascular events
Anyiam, A., Ardavani, A., Rashid, M., Panesar, K., & Idris, I
The role of the gut sweet taste receptor in regulating GLP-1, PYY, and CCK release in humans
The agencys public advisory notes that these unauthorised products may contain the wrong amount of active ingredient, unlisted dangerous ingredients, contaminants, or improper packaging
In a recent study published in the eClinicalMedicine , a group of researchers evaluated the association between Glucagon-like peptide-1 receptor agonists (GLP-1 RA) use and the risk of suicide or suicide attempt, accounting for psychiatric history and obesity